Ayala Pharmaceuticals (ADXS) Stock Chart & Stock Price History $0.03 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends Ayala Pharmaceuticals Stock Price Performance5 Day Performance+0.19%1 Month Performance-69.78%3 Month Performance+35.25%6 Month Performance-95.13%Year-To-Date Performance-95.94%1 Year Performance-96.96% Receive ADXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why ADXS Stock Chart for Monday, November, 4, 2024 ADXS Chart by TradingView Ayala Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$0.03$0.03$0.03$0.03283 shs$1.16 million11/01/2024$0.03$0.03$0.03$0.03122 shs$1.16 million10/31/2024$0.03$0.03+0.37%$0.03$0.03603 shs$1.16 million10/30/2024$0.03$0.03$0.03$0.034,668 shs$1.15 million10/29/2024$0.06$0.03-53.04%$0.03$0.034,668 shs$1.15 million10/28/2024$0.06$0.06$0.06$0.0638 shs$2.45 million Get the Latest News and Ratings for ADXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$0.06$0.06$0.06$0.066 shs$2.45 million10/24/2024$0.06$0.06$0.06$0.062,405 shs$2.45 million10/23/2024$0.03$0.06+112.96%$0.06$0.062,405 shs$2.45 million10/22/2024$0.03$0.03$0.03$0.03274 shs$1.15 million10/21/2024$0.03$0.03$0.11$0.031,471 shs$1.15 million10/18/2024$0.03$0.03$0.03$0.03112 shs$1.15 million10/17/2024$0.03$0.03$0.03$0.03463 shs$1.15 million10/16/2024$0.03$0.03$0.03$0.0320 shs$1.15 million10/15/2024$0.03$0.03$0.03$0.03138 shs$1.15 million10/14/2024$0.03$0.03$0.03$0.035,400 shs$1.15 million10/11/2024$0.03$0.03$0.03$0.0323 shs$1.15 million10/10/2024$0.03$0.03$0.03$0.035,499 shs$1.15 million10/09/2024$0.11$0.03-74.31%$0.03$0.035,499 shs$1.15 million10/08/2024$0.11$0.11$0.11$0.092,814 shs$4.48 million10/07/2024$0.09$0.11+17.43%$0.11$0.092,814 shs$4.48 million10/04/2024$0.09$0.09$0.09$0.099 shs$3.82 million10/03/2024$0.09$0.09$0.09$0.053,931 shs$3.82 million10/02/2024$0.03$0.09+231.48%$0.09$0.053,931 shs$3.82 million10/01/2024$0.11$0.03-74.31%$0.03$0.03391 shs$1.15 million09/30/2024$0.05$0.11+125.05%$0.11$0.03650 shs$4.48 million09/27/2024$0.05$0.05$0.05$0.031,247 shs$1.99 million09/26/2024$0.02$0.05+122.38%$0.05$0.031,247 shs$1.99 million09/25/2024$0.02$0.02+5.00%$0.02$0.022,818 shs$895,000.0009/24/2024$0.02$0.02$0.02$0.021,542 shs$853,000.0009/23/2024$0.10$0.02-80.21%$0.02$0.021,542 shs$853,000.0009/20/2024$0.10$0.10$0.10$0.023,084 shs$4.31 million09/19/2024$0.02$0.10+405.25%$0.10$0.023,084 shs$4.31 million09/18/2024$0.02$0.02$0.02$0.02180 shs$853,000.0009/17/2024$0.02$0.02$0.02$0.02180 shs$853,000.0009/16/2024$0.02$0.02$0.02$0.02117 shs$853,000.0009/13/2024$0.02$0.02$0.02$0.02331 shs$853,000.0009/12/2024$0.02$0.02$0.02$0.02956 shs$853,000.0009/11/2024$0.02$0.02$0.02$0.0233 shs$853,000.0009/10/2024$0.02$0.02$0.02$0.02537 shs$853,000.00Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade09/09/2024$0.02$0.02$0.02$0.021,047 shs$853,000.0009/06/2024$0.02$0.02$0.02$0.02206 shs$853,000.0009/05/2024$0.02$0.02$0.02$0.02519 shs$853,000.0009/04/2024$0.02$0.02$0.02$0.02519 shs$853,000.0009/03/2024$0.02$0.02$0.02$0.022,522 shs$853,000.0009/02/2024$0.02$0.02$0.02$0.02200 shs$853,000.0008/30/2024$0.02$0.02$0.02$0.02265 shs$853,000.0008/29/2024$0.02$0.02$0.02$0.0228 shs$853,000.0008/28/2024$0.02$0.02$0.02$0.022,004 shs$853,000.0008/27/2024$0.02$0.02$0.02$0.02504 shs$853,000.0008/26/2024$0.02$0.02$0.02$0.02507 shs$853,000.0008/23/2024$0.02$0.02-2.44%$0.02$0.02225 shs$853,000.0008/22/2024$0.02$0.02$0.02$0.02229 shs$874,000.0008/21/2024$0.02$0.02$0.02$0.02110 shs$874,000.0008/20/2024$0.02$0.02+2.50%$0.02$0.02175 shs$874,000.0008/19/2024$0.02$0.02$0.02$0.0225,651 shs$853,000.0008/16/2024$0.02$0.02-1.23%$0.02$0.02238 shs$853,000.0008/15/2024$0.02$0.02+1.25%$0.02$0.02255 shs$863,000.0008/14/2024$0.02$0.02$0.02$0.02646 shs$853,000.0008/13/2024$0.02$0.02$0.02$0.02611 shs$853,000.0008/12/2024$0.02$0.02$0.02$0.0253 shs$853,000.0008/09/2024$0.02$0.02$0.02$0.0253 shs$853,000.0008/08/2024$0.02$0.02$0.02$0.02595 shs$853,000.0008/07/2024$0.02$0.02$0.02$0.02165 shs$853,000.0008/06/2024$0.02$0.02$0.02$0.0232 shs$853,000.0008/05/2024$0.02$0.02$0.02$0.02249 shs$853,000.00 Related Companies Conduit Pharmaceuticals Stock Price Chart Viracta Therapeutics Stock Price Chart Can-Fite BioPharma Stock Price Chart Biodexa Pharmaceuticals Stock Price Chart Aptorum Group Stock Price Chart Imunon Stock Price Chart Vaxxinity Stock Price Chart Alterity Therapeutics Stock Price Chart Tenax Therapeutics Stock Price Chart Coeptis Therapeutics Stock Price Chart Receive ADXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ADXS) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ayala Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
